70 results
Page 3 of 4
8-K
EX-99.2
e5yo84xvk
27 Oct 21
Other Events
7:01am
8-K
EX-99.1
2w91q
14 Oct 21
Nurix Therapeutics Reports Third Quarter Fiscal 2021 Financial Results and Provides a Corporate Update
5:10pm
8-K
EX-99.1
sd2rf6
13 Jul 21
Nurix Therapeutics Reports Second Quarter Fiscal 2021 Financial Results and Provides a Corporate Update
4:12pm
8-K
39kjx8qlrcj7gsd
21 Jun 21
Departure of Directors or Certain Officers
4:17pm
8-K
EX-99.1
ovo3rzl
13 Apr 21
Nurix Therapeutics Reports First Quarter Fiscal 2021 Financial Results and Provides a Corporate Update
4:08pm
DEF 14A
78qks dsybcr
25 Mar 21
Definitive proxy
6:03am
10-K
f14gl5l rgksm
16 Feb 21
Annual report
4:11pm
10-K
EX-10.7
pkfo6 u08dmb9w27
16 Feb 21
Annual report
4:11pm
8-K
EX-99.1
mn4o3o trjtu46
16 Feb 21
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides a Corporate Update
4:05pm
8-K
1sexj61awlu7m8288w
7 Dec 20
Regulation FD Disclosure
6:06am
8-K
EX-99.1
we52ci 4449
14 Oct 20
Nurix Therapeutics Reports Third Quarter Fiscal 2020 Financial Results and Provides a Corporate Update
4:05pm
10-Q
vwwr4oynvuxyg0s
14 Oct 20
Quarterly report
4:02pm
8-K
EX-99.1
j3dvvsmt86097
14 Oct 20
Regulation FD Disclosure
2:01pm
424B4
r22 z8ayh9k2feu
24 Jul 20
Prospectus supplement with pricing info
4:06pm
S-1/A
EX-10.5
28y4ep063nkfdwadoa
20 Jul 20
IPO registration (amended)
6:32am